Abingdon Health (LON:ABDX) Issues Earnings Results

Abingdon Health (LON:ABDX) announced its quarterly earnings data on Monday. The company reported GBX (0.53) (($0.01)) earnings per share for the quarter, Digital Look Earnings reports. Abingdon Health had a negative return on equity of 62.56% and a negative net margin of 20.72%.

Abingdon Health Trading Up 3.6 %

Shares of Abingdon Health stock opened at GBX 6.73 ($0.09) on Wednesday. Abingdon Health has a 52-week low of GBX 6 ($0.08) and a 52-week high of GBX 11.75 ($0.15). The firm has a market capitalization of £13.04 million, a PE ratio of -16.37 and a beta of 0.13. The company has a debt-to-equity ratio of 46.64, a current ratio of 1.95 and a quick ratio of 1.96. The company’s fifty day moving average price is GBX 7.46 and its two-hundred day moving average price is GBX 7.96.

About Abingdon Health

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval.